A1.69 C1Q is absolutely required for disease development in experimental arthritis

Matthieu Ribon; Julie Mussard; Marina Botto; Marie-Christophe Boissier; Patrice Decker

doi:10.1136/annrheumdis-2013-205124.68

Article info

1. Rheumatoid arthritis

A1.69 C1Q is absolutely required for disease development in experimental arthritis

Authors

Matthieu Ribon 1University of Paris 13, Sorbonne Paris Cité, Inserm UMR 1125, Li2P, Bobigny, France PubMed articles Google scholar articles
Julie Mussard 1University of Paris 13, Sorbonne Paris Cité, Inserm UMR 1125, Li2P, Bobigny, France PubMed articles Google scholar articles
Marina Botto 2Department of Medicine, Imperial College, London, UK PubMed articles Google scholar articles
Marie-Christophe Boissier 1University of Paris 13, Sorbonne Paris Cité, Inserm UMR 1125, Li2P, Bobigny, France3Avicenne Hospital, Rheumatology Department, AP-HP, Bobigny, France PubMed articles Google scholar articles
Patrice Decker *Corresponding author1University of Paris 13, Sorbonne Paris Cité, Inserm UMR 1125, Li2P, Bobigny, France PubMed articles Google scholar articles

Citation

Ribon M, Mussard J, Botto M, et al

A1.69 C1Q is absolutely required for disease development in experimental arthritis

Annals of the Rheumatic Diseases 2014;73:A30.

Publication history

First published January 31, 2014.

Online issue publication

October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password